Actinium Pharmaceuticals, Inc. Contracts & Agreements
124 Contracts & Agreements
- Business Finance (53 contracts)
- Business Operations (7)
- Human Resources (16)
- Intellectual Property (4)
- Real Estate (2)
- Uncategorized (42)
- Fourth Amendment to the Actinium Pharmaceuticals, Inc. 2019 Plan (Filed With SEC on December 30, 2022)
- Exclusive License and Supply Agreement, dated April 7, 2022, between Immedica Pharma AB and Actinium Pharmaceuticals, Inc (Filed With SEC on August 12, 2022)
- Sublease Agreement, dated April 28, 2022, between ABN AMRO HOLDINGS USA LLC and Actinium Pharmaceuticals, Inc (Filed With SEC on August 12, 2022)
- Amended and Restated Capital on Demand Sales Agreement by and between Actinium Pharmaceuticals, Inc., JonesTrading Institutional Services LLC, and B. Riley Securities, Inc., dated... (Filed With SEC on June 29, 2022)
- Second Amendment to the Actinium Pharmaceuticals, Inc. 2019 Plan (Filed With SEC on November 9, 2021)
- Description of securities (Filed With SEC on March 31, 2021)
- Actinium Pharmaceuticals, Inc. 2019 Plan (Filed With SEC on November 20, 2020)
- Amendment to the Actinium Pharmaceuticals, Inc. 2019 Plan (Filed With SEC on November 20, 2020)
- Amendment to Warrant to Purchase Common Stock of Actinium Pharmaceuticals, Inc., dated March 14, 2017, issued to Sandesh Seth (Filed With SEC on August 14, 2020)
- Employment Agreement, dated August 12, 2020, by and between Actinium Pharmaceuticals, Inc. and Sandesh Seth (Filed With SEC on August 14, 2020)
- Employment Agreement, dated August 12, 2020, by and between Actinium Pharmaceuticals, Inc. and Steve OLoughlin (Filed With SEC on August 14, 2020)
- Employment Agreement, dated August 12, 2020, by and between Actinium Pharmaceuticals, Inc. and Dale Ludwig (Filed With SEC on August 14, 2020)
- Employment Agreement, dated August 12, 2020, by and between Actinium Pharmaceuticals, Inc. and Mark Berger (Filed With SEC on August 14, 2020)
- Form of Pre-funded Warrant (Filed With SEC on June 18, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on June 18, 2020)
- Underwriting Agreement, dated as of April 21, 2020, by and between Actinium Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on April 24, 2020)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on April 24, 2020)
- Underwriting Agreement, dated as of April 18, 2019, by and between Actinium Pharmaceuticals, Inc. and William Blair & Company, L.L.C (Filed With SEC on April 18, 2019)
- Form of Warrant (Filed With SEC on April 18, 2019)
- Consulting Agreement, dated December 21, 2018, between Actinium Pharmaceuticals, Inc. and Nitya Ray (Filed With SEC on March 15, 2019)
- Amended and Restated At Market Issuance Sales Agreement, dated December 28, 2018, by and among Actinium Pharmaceuticals, Inc. and B. Riley FBR, Inc. and JonesTrading Institutional... (Filed With SEC on March 15, 2019)
- Seventh Amendment to the 2013 Amended and Restated Stock Plan, as amended (Filed With SEC on March 15, 2019)
- Amendment to Actinium Pharmaceuticals, Inc. Warrant to Purchase Common Stock, dated November 8, 2018 issued to Amosan LLC (Filed With SEC on November 9, 2018)
- Amendment to Actinium Pharmaceuticals, Inc. Warrant to Purchase Common Stock, dated November 8, 2018 issued to Carnegie Hill Partners (Filed With SEC on November 9, 2018)
- Amendment to Actinium Pharmaceuticals, Inc. Warrant to Purchase Common Stock, dated November 8, 2018 issued to Bioche Asset Management, LLC (Filed With SEC on November 9, 2018)
- Purchase Agreement, dated as of October 18, 2018, by and between Actinium Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 18, 2018)
- Registration Rights Agreement, dated as of October 18, 2018, by and between Actinium Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 18, 2018)
- Employment Agreement, dated August 8, 2018, between Sandesh Seth and Actinium Pharmaceuticals, Inc (Filed With SEC on August 9, 2018)
- Employment Agreement, dated August 8, 2018, between Steve O'Loughlin and Actinium Pharmaceuticals, Inc (Filed With SEC on August 9, 2018)
- Director Agreement, dated April 27, 2018, by and between Jeffrey W. Chell and Actinium Pharmaceuticals, Inc (Filed With SEC on May 1, 2018)
- Indemnity Agreement, dated April 27, 2018, by and between Jeffrey W. Chell and Actinium Pharmaceuticals, Inc (Filed With SEC on May 1, 2018)
- Confidential Information and Invention Assignment Agreement, dated April 27, 2018, by and between Jeffrey W. Chell and Actinium Pharmaceuticals, Inc (Filed With SEC on May 1, 2018)
- Sixth Amendment to the 2013 Amended and Restated Stock Plan, as amended (Filed With SEC on March 16, 2018)
- Offer Letter, effective January 2, 2018, between Dale L. Ludwig and Actinium Pharmaceuticals, Inc (Filed With SEC on March 16, 2018)
- Indemnification Agreement, dated January 5, 2018, between Dale L. Ludwig and Actinium Pharmaceuticals, Inc (Filed With SEC on March 16, 2018)
- Offer Letter, effective January 31, 2018, between Anil Kapur and Actinium Pharmaceuticals, Inc (Filed With SEC on March 16, 2018)
- Indemnification Agreement, dated February 8, 2018, between Anil Kapur and Actinium Pharmaceuticals, Inc (Filed With SEC on March 16, 2018)
- Revised Form of Non-Transferable Subscription Rights Certificate (Filed With SEC on February 26, 2018)
- Dealer-Manager Agreement, dated February 15, 2018, between Maxim Group LLC and Actinium Pharmaceuticals, Inc (Filed With SEC on February 15, 2018)
- Form of Warrant Agency Agreement between Action Stock Transfer Corporation and Actinium Pharmaceuticals, Inc (Filed With SEC on February 15, 2018)
- Form of Series A Warrant (Filed With SEC on February 15, 2018)
- Form of Series B Warrant (Filed With SEC on February 15, 2018)
- Form of Non-Transferable Subscription Rights Certificate (Filed With SEC on February 15, 2018)
- Assignment and Consent Agreement, dated June 6, 2017, among 275 Madison Avenue RPW 1 LLC, 275 Madison Avenue RPW 2, LLC, Actinium Pharmaceuticals, Inc. and Relmada Therapeutics,... (Filed With SEC on August 4, 2017)
- Amended and Restated License Agreement, dated June 8, 2017, between Actinium Pharmaceuticals, Inc. and Relmada Therapeutics, Inc (Filed With SEC on August 4, 2017)
- Offer Letter; dated May 26, 2017, by and between Actinium Pharmaceuticals, Inc. and Dr. Nitya G. Ray (Filed With SEC on August 4, 2017)
- Amended and Restated At-the-Market Market Issuance Sales Agreement, dated July 3, 2017, among FBR Capital Markets & Co., JonesTrading Institutional Services LLC, and MLV & Co. LLC (Filed With SEC on August 4, 2017)
- Agreement, dated June 6, 2017, by and between Actinium Pharmaceuticals, Inc. and Sergio Traversa (Filed With SEC on August 4, 2017)
- Consulting Agreement, dated May 22, 2017, by and between Actinium Pharmaceuticals, Inc. and Dragan Cicic (Filed With SEC on August 4, 2017)
- Separation and Settlement Agreement, dated May 12, 2017, by and between Actinium Pharmaceuticals, Inc. and Kaushik Dave (Filed With SEC on August 4, 2017)
- Separation and Settlement Agreement, dated May 12, 2017, by and between Actinium Pharmaceuticals, Inc. and Dragan Cicic (Filed With SEC on August 4, 2017)
- Underwriting Agreement, dated as of July 28, 2017, by and between Actinium Pharmaceuticals, Inc. and Oppenheimer & Co. Inc.. as representative of the several underwriters party... (Filed With SEC on July 28, 2017)
- Form of Warrant (Filed With SEC on July 28, 2017)
- Employment Agreement, dated September 17, 2015, by and between Actinium Pharmaceuticals, Inc. and Steve OLoughlin (Filed With SEC on May 15, 2017)
- Indemnity Agreement, dated May 15, 2017, by and between Actinium Pharmaceuticals, Inc. and Steve OLoughlin (Filed With SEC on May 15, 2017)
- Amendment to Amended and Restated Consulting Agreement, dated May 5, 2017, between Sandesh Seth and Actinium Pharmaceuticals, Inc (Filed With SEC on May 11, 2017)
- INDEMNIFICATIONAGREEMENT (Filed With SEC on March 28, 2017)
- ActiniumPharmaceuticals, Inc. CONFIDENTIALINFORMATION AND INVENTION ASSIGNMENT AGREEMENT (Filed With SEC on March 28, 2017)
- AMENDMENTNO. 5 TO ACTINIUM PHARMACEUTICALS, INC. 2013 AMENDED AND RESTATED STOCK PLAN (Filed With SEC on March 16, 2017)
- AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 16, 2017)
- AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 16, 2017)
- WARRANTTO PURCHASE COMMON STOCK of ACTINIUMPHARMACEUTICALS, INC. Voidafter February 11, 2022 (Filed With SEC on March 16, 2017)
- ActiniumPharmaceuticals, Inc. CONFIDENTIALINFORMATION AND INVENTION ASSIGNMENT AGREEMENT (Filed With SEC on March 16, 2017)
- INDEMNIFICATIONAGREEMENT (Filed With SEC on March 16, 2017)
- ACTINIUM PHARMACEUTICALS, INC. FOURTH AMENDMENT TO THE AMENDED AND RESTATED 2013 STOCK PLAN (Filed With SEC on December 14, 2016)
- ACTINIUMPHARMACEUTICALS, INC. 8,000,000 Shares CommonStock ($0.001par value) UnderwritingAgreement (Filed With SEC on September 29, 2016)
- THIRD AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. 2013 AMENDED AND RESTATED STOCK PLAN (Filed With SEC on March 11, 2016)
- OFFICESPACE LICENSE AGREEMENT (Filed With SEC on March 11, 2016)
- INVESTORS’RIGHTS AGREEMENT BY AND BETWEEN ACTINIUM PHARMACEUTICALS, INC. AND MEMORIAL SLOAN KETTERING CANCER CENTER (Filed With SEC on December 24, 2015)
- ACTINIUM PHARMACEUTICALS, INC. SECOND AMENDMENT TO THE AMENDED AND RESTATED 2013 STOCK PLAN (Filed With SEC on December 16, 2015)
- ACTINIUM PHARMACEUTICALS, INC. FIRST AMENDMENT TO THE AMENDED AND RESTATED 2013 STOCK PLAN (Filed With SEC on August 7, 2015)
- ACTINIUMPHARMACEUTICALS, INC. FIRSTAMENDMENT TO THE AMENDED AND RESTATED 2013 EQUITY INCENTIVE PLAN (Filed With SEC on August 7, 2015)
- FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on August 7, 2015)
- Effective Date: August 6, 2015 (Filed With SEC on August 7, 2015)
- ACTINIUM PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share Placement Agent Agreement (Filed With SEC on June 5, 2015)
- SUBSCRIPTIONAGREEMENT (Filed With SEC on June 5, 2015)
- AGREEMENT (Filed With SEC on May 8, 2015)
- ACTINIUMPHARMACEUTICALS, INC. Amendedand Restated Stock Plan (Filed With SEC on March 16, 2015)
- EffectiveDate: August 11, 2014 (Filed With SEC on March 16, 2015)
- ACTINIUMPHARMACEUTICALS, INC. AMENDED AND RESTATED 2013 EQUITYINCENTIVE PLAN (Filed With SEC on March 16, 2015)
- ACTINIUMPHARMACEUTICALS, INC. CommonStock, par value $0.001 per share Warrantsto Purchase Shares of Common Stock UnderwritingAgreement (Filed With SEC on February 6, 2015)
- ACTINIUM PHARMACEUTICALS, INC. Warrantto Purchase Common Stock (Filed With SEC on February 6, 2015)
- ACTINIUM PHARMACEUTICALS, INC. 1,670,000 Shares Common Stock ($0.001 par value) Underwriting Agreement Underwriting Agreement (Filed With SEC on June 25, 2014)
- SUBLEASE AGREEMENT (Filed With SEC on May 12, 2014)
- COMMON STOCK PURCHASE WARRANT ACTINIUM PHARMACEUTICALS, INC. (Filed With SEC on January 31, 2014)
- FORM OF LOCK-UP AGREEMENT (Filed With SEC on January 31, 2014)
- ACTINIUM PHARMACEUTICALS, INC. Amended and Restated 2013 STOCK PLAN (Filed With SEC on January 31, 2014)
- ACTINIUM PHARMACEUTICALS, INC.AMENDED AND RESTATED 2013 EQUITY INCENTIVE PLAN (Filed With SEC on January 31, 2014)
- UNIT PURCHASE AGREEMENT (Filed With SEC on January 31, 2014)
- To subscribe for Units in the private offering of ACTINIUM PHARMACEUTICALS, INC. (Filed With SEC on January 31, 2014)
- ACTINIUM PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 31, 2014)
- TRANSACTION MANAGEMENT AGREEMENT (Filed With SEC on September 30, 2013)
- ACTINIUM PHARMACEUTICALS, INC. 2013 STOCK PLAN (Filed With SEC on September 13, 2013)
- ACTINIUM PHARMACEUTICALS, INC. 2013 STOCK PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on September 13, 2013)
- ACTINIUM PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on September 13, 2013)
- RESTRICTED STOCK AGREEMENT (Filed With SEC on September 13, 2013)
- LOCK-UP LETTER AGREEMENT (Filed With SEC on August 22, 2013)
- SHARE EXCHANGE AGREEMENT (Filed With SEC on March 11, 2013)
- REGISTRATION RIGHTS AGREEMENT among ACTINIUM PHARMACEUTICALS, INC., GENERAL ATLANTIC INVESTMENTS LIMITED, N.V. ORGANON, ISOTOPIA B.V. DR. MAURITS W. GEERLINGS, SR., DR. MAURITS W.... (Filed With SEC on January 4, 2013)
- AMENDMENT No. 1 TO (Filed With SEC on January 4, 2013)
- FIRST AMENDED AND RESTATED STOCKHOLDERS AGREEMENT AMONG ACTINIUM PHARMACEUTICALS, INC., ACTINIUM HOLDINGS LIMITED (FORMERLY GENERAL ATLANTIC INVESTMENTS LIMITED), N.V. ORGANON AND... (Filed With SEC on January 4, 2013)
- SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT BY AND AMONG ACTINIUM PHARMACEUTICALS, INC. ACTINIUM HOLDINGS LIMITED AND THE INVESTORS PARTY HERETO October 5, 2011 SECOND... (Filed With SEC on January 4, 2013)
- LAIDLAW & COMPANY (UK) LTD. 90 Park Avenue41 Dover StreetNew York, NY 10016W1S 4NS London * Member FINRA, SIPC* *Incorporated in England & Wales: Company No. 3870324* *Authorized... (Filed With SEC on January 4, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on January 4, 2013)
- Monday, April 14, 2003 (3).max (Filed With SEC on January 4, 2013)
- An Operating Division of Averion International Corp. *CONFIDENTIAL* (Filed With SEC on January 4, 2013)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on January 4, 2013)
- Actinium Pharmaceuticals, Inc. (Filed With SEC on January 4, 2013)
- Actinium Pharmaceuticals, Inc. July 21, 2012 (Filed With SEC on January 4, 2013)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on January 4, 2013)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on January 4, 2013)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on January 4, 2013)
- LICENSE AGREEMENT (Filed With SEC on January 4, 2013)
- 2012 UNIT INVESTOR RIGHTS AGREEMENT (Filed With SEC on January 4, 2013)
- Project Agreement Number: 1 Aptiv Project Number: ACTI-1903 (Filed With SEC on January 4, 2013)
- Proposal for Actinium Pharmaceuticals, Inc. 225Ac-Labeling of HuM195 March 30, 2007 (Filed With SEC on January 4, 2013)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on January 4, 2013)
- AMENDMENT No. 1 TO RESEARCH AGREEMENT (Filed With SEC on January 4, 2013)
- Actinium Pharmaceuticals, Inc. (Filed With SEC on January 4, 2013)
- Sloan-Kettering Institute for Cancer Research 1275 York Avenue New York, NY 10021 (Filed With SEC on January 4, 2013)
- CLINICAL TRIAL AGREEMENT (SK#11731) (Filed With SEC on January 4, 2013)
- SHARE EXCHANGE AGREEMENT BY AND AMONG CACTUS VENTURES, INC. AND DIANE S. BUTTON AND ACTINIUM PHARMECEUTICALS, INC. AND THE SHAREHOLDERS OF ACTINIUM PHARMECEUTICALS, INC. Dated as... (Filed With SEC on January 2, 2013)
- LOCK-UP LETTER AGREEMENT (Filed With SEC on January 2, 2013)
- UNIT PURCHASE AGREEMENT BY AND AMONG ACTINIUM PHARMACEUTICALS, INC. AND THE PURCHASERS PARTY HERETO October __, 2012 SCHEDULES AND EXHIBITS TO UNIT PURCHASE AGREEMENT (Filed With SEC on January 2, 2013)
